Migraine in the real-life clinical practice: results of the observational study of diagnosis and treatment patterns in the urban population of the Russian Federation

Tabeeva G.R.; Katsarava Z.; Dmitriev G.V.; Lyubovnaya Y.O.; Kovalchuk N.A.

doi:https://doi.org/10.17116/jnevro202112112140

Tabeeva G.R.

Sechenov First Moscow State Medical University

Katsarava Z.

Sechenov First Moscow State Medical University (Sechenov University);
University of Duisburg-Essen;
Evangelical Hospital;
EVEX Medical Corporation

Dmitriev G.V.

Novartis Pharma LLC

Lyubovnaya Y.O.

Novartis Pharma LLC

Kovalchuk N.A.

Sechenov First Moscow State Medical University (Sechenov University)

Migraine in the real-life clinical practice: results of the observational study of diagnosis and treatment patterns in the urban population of the Russian Federation

Authors:

Tabeeva G.R., Katsarava Z., Dmitriev G.V., Lyubovnaya Y.O., Kovalchuk N.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(12): 40‑50

DOI: 10.17116/jnevro202112112140

Read: 2976 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tabeeva GR, Katsarava Z, Dmitriev GV, Lyubovnaya YO, Kovalchuk NA. Migraine in the real-life clinical practice: results of the observational study of diagnosis and treatment patterns in the urban population of the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(12):40‑50. (In Russ.)
https://doi.org/10.17116/jnevro202112112140

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

Analysis of real-life clinical practice data regarding the patterns of diagnosis and treatment of migraine in the Russian Federation.

MATERIAL AND METHODS

An observational real-world cohort study was conducted from January 2013 to December 2018 (over a 5-year period) to analyze the electronic database of 5 large private clinic chains in Moscow and St. Petersburg.

RESULTS

Among 1.15 million people who sought medical care, «G43 Migraine» diagnosis was established in 6.650 people, which accounted for 0.6%. A total of 54% of patients were diagnosed by a neurologist, while 35% by a GP. In roughly half the cases, to diagnose migraine, the doctors had to resort to additional methods of examination. While 53% of patients had indications for preventive treatment, it was prescribed only to 12% of those. Of these, the treatment strategy chosen for 29% of patients was changed: either the intragroup/intergroup switching of the medicinal product took place, or the combined treatment was prescribed.

CONCLUSION

In the real-life outpatient clinical practice, the level of diagnosis of migraine is extremely low. Additional methods of examination are excessively used for the diagnosis of migraine. The insufficient use of preventive medication and common use of therapies with unsubstantiated efficacy in migraine result in frequent changes in the treatment strategy.

Keywords:

migraine

preventive treatment

triptans

MRI

real-life clinical practice

Authors:

Tabeeva G.R.

Sechenov First Moscow State Medical University

Katsarava Z.

Sechenov First Moscow State Medical University (Sechenov University);
University of Duisburg-Essen;
Evangelical Hospital;
EVEX Medical Corporation

Dmitriev G.V.

Novartis Pharma LLC

Lyubovnaya Y.O.

Novartis Pharma LLC

Kovalchuk N.A.

Sechenov First Moscow State Medical University (Sechenov University)

Received:

09.11.2021

Accepted:

17.11.2021

Close metadata

References:

Leonardi M, Raggi A. A narrative review on the burden of migraine: when the burden is the impact on people’s life. J Headache Pain. 2019;20(1):41. https://doi.org/10.1186/s10194-019-0993-0
Ayzenberg I, Katsarava Z, Sborowski A, et al. On behalf of Lifting the Burden The prevalence of primary headache disorders in Russia: A countrywide survey. Cephalalgia. 2012;32:373-381. https://doi.org/10.1177/0333102412438977
Lebedeva ER, Kobzeva NR, Gilev DV, et al. Prevalence of primary headache disorders diagnosed according ICHD-3 beta in three different social groups. Cephalalgia. 2016;36(6):579-588. https://doi.org/10.1177/0333102415596442
Azimova YuE, Sergeev AV, Osipova VV, Tabeeva GR. Diagnostic and treatment of headaches in Russia: results of questionnaire-based survey. Rossijskiij Zhurnal Boli. 2010;4:12-17. (In Russ.).
Kovalchuk NA, Kiryanova EA, Tabeeva GR. Adherence in patients with migraine (according to an Internet survey). Nevrologiya, Nejropsihiatriya, Psihosomatika. 2021;13(4):81-87. (In Russ.). https://doi.org/10.14412/2074-2711-2021-4-81-87
GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990—2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16:877-897. https://doi.org/10.1016/S1474-4422(17)30299-5
Steiner TJ, Stovner LJ, Katsarava Z, et al. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain. 2014;15:31-38. https://doi.org/10.1186/1129-2377-15-31
Лебедева Е.Р., Кобзева Н.Р., Гилев Д.В. и др. Анализ качества диагностики и лечения первичной головной боли в разных социальных группах Уральского региона. Неврология, нейропсихиатрия, психосоматика. 2015;1:19-26.
Lebedeva ER, Kobzeva NR, Gilev DV. et al. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural region. Nevrologiya, Nejropsihiatriya, Psihosomatika. 2015;1:19-26. (In Russ.). https://doi.org/10.14412/2074-2711-2015-1-19-26
Lebedeva ER, Kobseva NR. The quality od diagnosis and management of migraine and tensiontype headache in three social groups in Russia. Cephalalgia. 2017;37(3):225-235. https://doi.org/10.1177/0333102416642603
Osipova VV, Filatova EG, Artemenko AR, et al. Diagnostics and treatment of migraine: recommendations of Russian experts. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;1:2:28-42. (In Russ.). https://doi.org/10.17116/jnevro20171171228-42
Korolainen MA, Kurki S, Lassenius MI, et al. Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care. J Headache Pain. 2019;20(1):13. https://doi.org/10.1186/s10194-019-0964-5
Takaki H, Onozuka D, Hagihara A. Migraine‐preventive prescription patterns by physician specialty in ambulatory care settings in the United States. Prev Med Rep. 2017;9:62‐67. https://doi.org/10.1016/j.pmedr.2017.12.009
Thomsen RW, Szépligeti SK, Xue F, et al. Patterns of initial migraine treatment in Denmark: A population-based study. Pharmacoepidemiol Drug Saf. 2019;28(3):322-329. https://doi.org/10.1002/pds.4723
Frisk P, Sporrong SK, Ljunggren G, et al. Utilisation of prescription and over‐the‐counter triptans: a cross‐sectional study in Stockholm, Sweden. Eur J Clin Pharmacol. 2016;72(6):747‐754. https://doi.org/10.1007/s00228-016-2028-y
Hepp Z, Dodick DW, Varon SF, et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia. 2017;37(5):470‐485. https://doi.org/10.1177/0333102416678382
Katsarava Z, Mania M, Lampl C, et al. Poor medical care for people with migraine in Europe — evidence from the Eurolight study. J Headache Pain. 2018;19:10-16. https://doi.org/10.1186/s10194-018-0839-1
Yoon MS, Katsarava Z, Obermann M, et al. Prevalence of headaches in Germany: results of the German headache consortium study. J Headache Pain. 2012;13:215-223. https://doi.org/10.1007/s10194-012-0425-x
Lucas C, Géraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache. 2006;46:715-725. https://doi.org/10.1111/j.1526-4610.2006.00430.x
Cevoli S, D’Amico D, Martelletti P, et al. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia. 2009;29:1285-1293. https://doi.org/10.1111/j.1468-2982.2009.01874.x
Callaghan BC, Kerber KA, Pace R, et al. Headache neuroimaging: routine testing when guidelines recommend against them. Cephalalgia. 2015;35(13):1144-1152. https://doi.org/10.1177/0333102415572918
De Tommaso M. An update on EEG in migraine. Expert Rev Neurother. 2019;19(8):729-737. https://doi.org/10.1080/14737175.2019.1586534
Steiner TJ, Antonaci F, Jensen R, et al. Recommendations for headache service organisation and delivery in Europe. J Headache Pain. 2011;12:419-426. https://doi.org/10.1007/s10194-011-0320-x
Табеева Г.Р., Амелин А.В., Ахмадеева Л.Р. и др. Пути оптимизации ведения пациентов с мигренью в России (резолюция совета экспертов). Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(6):124-128.
Tabeeva GR, Amelin AV, Akhmadeeva LR, et al. Ways to optimize the management of migraine patients in Russia (resolution of the expert council). Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2018;118(6):124-128. (In Russ.). https://doi.org/10.17116/jnevro201811861124